Carthera
@carthera.bsky.social
#MedTech #startup developing innovative therapeutic ultrasound-based medical devices to treat brain disorders 🧠
🖥️ Website: carthera.eu
🥼 Glioblastoma trial: sonobird.eu
#Oncology #Neurology #Glioblastoma #Alzheimers #SonoCloud
🖥️ Website: carthera.eu
🥼 Glioblastoma trial: sonobird.eu
#Oncology #Neurology #Glioblastoma #Alzheimers #SonoCloud
Pinned
Carthera
@carthera.bsky.social
· Oct 2
Carthera | LinkedIn
Carthera | 6,995 followers on LinkedIn. Advanced Brain Therapy | Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range o...
www.linkedin.com
📢 Update: this account will no longer be active.
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
📢 Update: this account will no longer be active.
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
Carthera | LinkedIn
Carthera | 6,995 followers on LinkedIn. Advanced Brain Therapy | Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range o...
www.linkedin.com
October 2, 2025 at 12:22 PM
📢 Update: this account will no longer be active.
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
Breaking Barriers: How Carthera’s SonoCloud Offers New Perspectives to Brain Cancer Patients 🧠
The American Brain Tumor Association has published an informative article for patients about our SonoCloud technology and how it's being used to treat glioblastoma.
www.abta.org/mindmatters/...
The American Brain Tumor Association has published an informative article for patients about our SonoCloud technology and how it's being used to treat glioblastoma.
www.abta.org/mindmatters/...
September 26, 2025 at 1:28 PM
Breaking Barriers: How Carthera’s SonoCloud Offers New Perspectives to Brain Cancer Patients 🧠
The American Brain Tumor Association has published an informative article for patients about our SonoCloud technology and how it's being used to treat glioblastoma.
www.abta.org/mindmatters/...
The American Brain Tumor Association has published an informative article for patients about our SonoCloud technology and how it's being used to treat glioblastoma.
www.abta.org/mindmatters/...
🗓️ Meet the Carthera team from next week for the latest insights into our Phase III study evaluating SonoCloud 9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
September 24, 2025 at 12:33 PM
🗓️ Meet the Carthera team from next week for the latest insights into our Phase III study evaluating SonoCloud 9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
Finding a #braintumor clinical trial can be overwhelming.
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
Ancora - Find Cancer Clinical Trials
Ancora is a search tool that enables cancer patients to find relevant clinical trials in minutes. Radiopharmaceutical trial finder, nuclear medicine.
www.ancora.ai
September 18, 2025 at 12:06 PM
Finding a #braintumor clinical trial can be overwhelming.
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
🗓️ Meet the Carthera team in October for the latest insights into our Phase III study evaluating SonoCloud‑9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
September 9, 2025 at 3:35 PM
🗓️ Meet the Carthera team in October for the latest insights into our Phase III study evaluating SonoCloud‑9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
GLIOBLASTOMA TRIAL UPDATE 📣
Sonobird is now active in Denmark! 🇩🇰
Two weeks ago, the team at University of Copenhagen included the first Danish patient.
To learn more about the trial including active recruitment centres 👇
sonobird.eu
#Glioblastoma #ClinicalTrial #NeuroOncology
Sonobird is now active in Denmark! 🇩🇰
Two weeks ago, the team at University of Copenhagen included the first Danish patient.
To learn more about the trial including active recruitment centres 👇
sonobird.eu
#Glioblastoma #ClinicalTrial #NeuroOncology
SONOBIRD: a pivotal trial in recurrent glioblastoma
SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...
sonobird.eu
September 5, 2025 at 9:06 AM
GLIOBLASTOMA TRIAL UPDATE 📣
Sonobird is now active in Denmark! 🇩🇰
Two weeks ago, the team at University of Copenhagen included the first Danish patient.
To learn more about the trial including active recruitment centres 👇
sonobird.eu
#Glioblastoma #ClinicalTrial #NeuroOncology
Sonobird is now active in Denmark! 🇩🇰
Two weeks ago, the team at University of Copenhagen included the first Danish patient.
To learn more about the trial including active recruitment centres 👇
sonobird.eu
#Glioblastoma #ClinicalTrial #NeuroOncology
🎙️ Our CSO Michael Canney was recently featured on the Med Tech Gurus podcast, where he dives into how our SonoCloud technology works and its potential to revolutionize glioblastoma care
www.youtube.com/watch?v=3kUF...
#NeuroOncology #ClinicalTrials #Glioblastoma #MedTech
www.youtube.com/watch?v=3kUF...
#NeuroOncology #ClinicalTrials #Glioblastoma #MedTech
Breaking Barriers
YouTube video by Med Tech Gurus
www.youtube.com
September 2, 2025 at 1:06 PM
🎙️ Our CSO Michael Canney was recently featured on the Med Tech Gurus podcast, where he dives into how our SonoCloud technology works and its potential to revolutionize glioblastoma care
www.youtube.com/watch?v=3kUF...
#NeuroOncology #ClinicalTrials #Glioblastoma #MedTech
www.youtube.com/watch?v=3kUF...
#NeuroOncology #ClinicalTrials #Glioblastoma #MedTech
Summer Review: Transforming Glioblastoma Treatment 🧠
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
August 28, 2025 at 11:37 AM
Summer Review: Transforming Glioblastoma Treatment 🧠
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
📣 Our CSO Michael Canney discussed our innovative approach to treating recurrent #glioblastoma on the Brain Wellness podcast. He explains how we use therapeutic ultrasound to enhance chemotherapy delivery to the brain.
www.youtube.com/watch?v=KcUu...
#MedTech #BrainCancer #ClinicalTrials
www.youtube.com/watch?v=KcUu...
#MedTech #BrainCancer #ClinicalTrials
Brain Wellness - episode 145: Using ultrasound to treat glioblastoma with Michael Canney
YouTube video by Brain Wellness NP
www.youtube.com
August 20, 2025 at 11:39 AM
📣 Our CSO Michael Canney discussed our innovative approach to treating recurrent #glioblastoma on the Brain Wellness podcast. He explains how we use therapeutic ultrasound to enhance chemotherapy delivery to the brain.
www.youtube.com/watch?v=KcUu...
#MedTech #BrainCancer #ClinicalTrials
www.youtube.com/watch?v=KcUu...
#MedTech #BrainCancer #ClinicalTrials
📣 Our CSO, Michael Canney talks all things Sonobird on the Bindwaves podcast. Learn about SonoCloud-9, our ultrasound implant that disrupts the blood-brain barrier to enhance the delivery of therapeutic drugs.
www.youtube.com/watch?v=B2_D...
#Glioblastoma #BrainCancer #Oncology #ClinicalTrials
www.youtube.com/watch?v=B2_D...
#Glioblastoma #BrainCancer #Oncology #ClinicalTrials
www.youtube.com
August 13, 2025 at 10:50 AM
📣 Our CSO, Michael Canney talks all things Sonobird on the Bindwaves podcast. Learn about SonoCloud-9, our ultrasound implant that disrupts the blood-brain barrier to enhance the delivery of therapeutic drugs.
www.youtube.com/watch?v=B2_D...
#Glioblastoma #BrainCancer #Oncology #ClinicalTrials
www.youtube.com/watch?v=B2_D...
#Glioblastoma #BrainCancer #Oncology #ClinicalTrials
This trial involves 40+ clinical sites in the EU & US, evaluating our SonoCloud device to temporarily open the blood-brain barrier and enhance chemotherapy delivery for recurrent #glioblastoma patients
Learn more about the trial and clinical sites in Italy👇
sonobird.eu
#clinicaltrials #medtech
Learn more about the trial and clinical sites in Italy👇
sonobird.eu
#clinicaltrials #medtech
SONOBIRD: a pivotal trial in recurrent glioblastoma
SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...
sonobird.eu
August 6, 2025 at 2:05 PM
This trial involves 40+ clinical sites in the EU & US, evaluating our SonoCloud device to temporarily open the blood-brain barrier and enhance chemotherapy delivery for recurrent #glioblastoma patients
Learn more about the trial and clinical sites in Italy👇
sonobird.eu
#clinicaltrials #medtech
Learn more about the trial and clinical sites in Italy👇
sonobird.eu
#clinicaltrials #medtech
📣 We’re thrilled to announce that our phase 3 trial for recurrent #glioblastoma has launched in Italy with the first patient enrolled in Bologna 🇮🇹
Prof. Giuseppe Lombardi, Italy’s referring investigator and site lead in Padua recently spoke about the trial.
Watch the interview👇
bit.ly/4msq3gX
Prof. Giuseppe Lombardi, Italy’s referring investigator and site lead in Padua recently spoke about the trial.
Watch the interview👇
bit.ly/4msq3gX
Padova, un "device" a ultrasuoni per combattere il glioblastoma
Affidato allo Iov il coordinamento di un innovativo progetto internazionale per rendere molto più efficaci le terapie per contrastare questo aggressivo tumore cerebrale
bit.ly
August 6, 2025 at 2:03 PM
📣 We’re thrilled to announce that our phase 3 trial for recurrent #glioblastoma has launched in Italy with the first patient enrolled in Bologna 🇮🇹
Prof. Giuseppe Lombardi, Italy’s referring investigator and site lead in Padua recently spoke about the trial.
Watch the interview👇
bit.ly/4msq3gX
Prof. Giuseppe Lombardi, Italy’s referring investigator and site lead in Padua recently spoke about the trial.
Watch the interview👇
bit.ly/4msq3gX
A new study has identified genes responsible for the spread of #glioblastoma, opening up new avenues for treatment. This breakthrough could pave the way for more effective therapies and improved patient outcomes.
Learn more👇
www.insideprecisionmedicine.com/topics/oncol...
#BrainTumor #Oncology
Learn more👇
www.insideprecisionmedicine.com/topics/oncol...
#BrainTumor #Oncology
Genes Causing Spread of Glioblastoma Open Treatment Avenues
New research shows how glioblastoma cells infiltrate the brain and which key genes drive the invasion, paving the way to new treatments.
www.insideprecisionmedicine.com
August 1, 2025 at 9:00 AM
A new study has identified genes responsible for the spread of #glioblastoma, opening up new avenues for treatment. This breakthrough could pave the way for more effective therapies and improved patient outcomes.
Learn more👇
www.insideprecisionmedicine.com/topics/oncol...
#BrainTumor #Oncology
Learn more👇
www.insideprecisionmedicine.com/topics/oncol...
#BrainTumor #Oncology
🧠 Purdue University Researchers Develop a Novel Human Brain Model to Study Alzheimer’s Disease
vet.purdue.edu/news/purdue-...
#Alzheimers
vet.purdue.edu/news/purdue-...
#Alzheimers
Purdue Researchers Develop a Novel Human Brain Model to Study Alzheimer's Disease
Purdue University College of Veterinary Medicine researchers are taking an innovative approach to studying Alzheimer’s disease. Dr. Ranjie Xu, an assistant professor in the Department of Basic Medical...
vet.purdue.edu
July 24, 2025 at 1:20 PM
🧠 Purdue University Researchers Develop a Novel Human Brain Model to Study Alzheimer’s Disease
vet.purdue.edu/news/purdue-...
#Alzheimers
vet.purdue.edu/news/purdue-...
#Alzheimers
🧠 On #GlioblastomaDay, we stand with the global call for better awareness, research & treatments.
Only four FDA-approved drugs & one device exist, we are working to change this through our SonoCloud system.
Read Lynn's story - a patient in our Sonobird trial👇
www.med.unc.edu/neurosurgery...
Only four FDA-approved drugs & one device exist, we are working to change this through our SonoCloud system.
Read Lynn's story - a patient in our Sonobird trial👇
www.med.unc.edu/neurosurgery...
Glioblastoma Patient Joins the Sonobird Clinical Trial at UNC Health | Department of Neurosurgery
Lynn lives an active lifestyle as an owner of her own luxury traveling tours business. But when she got back from a corporate cruise in November of 2023, she started to feel sick every day. Lynn was q...
www.med.unc.edu
July 16, 2025 at 11:11 AM
🧠 On #GlioblastomaDay, we stand with the global call for better awareness, research & treatments.
Only four FDA-approved drugs & one device exist, we are working to change this through our SonoCloud system.
Read Lynn's story - a patient in our Sonobird trial👇
www.med.unc.edu/neurosurgery...
Only four FDA-approved drugs & one device exist, we are working to change this through our SonoCloud system.
Read Lynn's story - a patient in our Sonobird trial👇
www.med.unc.edu/neurosurgery...
🔊 New podcast!
Our CSO Dr. Michael Canney joins “Michael and Mom” to talk about the BBB, glioblastoma, and how SonoCloud is changing drug delivery to the brain.
Listen here: www.youtube.com/watch?v=lvRU...
#Glioblastoma #Oncology #ClinicalTrial
Our CSO Dr. Michael Canney joins “Michael and Mom” to talk about the BBB, glioblastoma, and how SonoCloud is changing drug delivery to the brain.
Listen here: www.youtube.com/watch?v=lvRU...
#Glioblastoma #Oncology #ClinicalTrial
Michael & Mom Talk Glioblastoma Trial: Episode 63, Using Ultrasound to Break the Blood Brain Barrier
YouTube video by Michael and Mom Inspire
www.youtube.com
July 9, 2025 at 8:41 AM
🔊 New podcast!
Our CSO Dr. Michael Canney joins “Michael and Mom” to talk about the BBB, glioblastoma, and how SonoCloud is changing drug delivery to the brain.
Listen here: www.youtube.com/watch?v=lvRU...
#Glioblastoma #Oncology #ClinicalTrial
Our CSO Dr. Michael Canney joins “Michael and Mom” to talk about the BBB, glioblastoma, and how SonoCloud is changing drug delivery to the brain.
Listen here: www.youtube.com/watch?v=lvRU...
#Glioblastoma #Oncology #ClinicalTrial
Exciting news! Our SonoCloud is among the first devices to receive a positive opinion from the EMA expert panel for Orphan Medical Device status, targeting recurrent glioblastoma. A big step toward CE marking!
ala.associates/regulatory/c...
#Glioblastoma #Oncology #MedTech #NeuroOncology
ala.associates/regulatory/c...
#Glioblastoma #Oncology #MedTech #NeuroOncology
July 1, 2025 at 9:03 AM
Exciting news! Our SonoCloud is among the first devices to receive a positive opinion from the EMA expert panel for Orphan Medical Device status, targeting recurrent glioblastoma. A big step toward CE marking!
ala.associates/regulatory/c...
#Glioblastoma #Oncology #MedTech #NeuroOncology
ala.associates/regulatory/c...
#Glioblastoma #Oncology #MedTech #NeuroOncology
Our CSO was recently featured on The Childhood Cancer Perspective
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
S5:E78 Interview with Dr. Michael Canney
YouTube video by Battlecorn Care Packages
www.youtube.com
June 26, 2025 at 8:14 AM
Our CSO was recently featured on The Childhood Cancer Perspective
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
Our CSO was recently featured on the PsyDactic podcast!
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
Therapeutic Ultrasound with Dr. Michael Canney PhD - PsyDactic
This episode includes a fascinating interview with a researcher in ultrasound, Dr. Michael Canney who is an acoustics researcher the chief scientific officer at a French company named Carthera (https:...
psydactic.buzzsprout.com
June 13, 2025 at 7:53 AM
Our CSO was recently featured on the PsyDactic podcast!
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
Le Pr. Olivier Chinot de @aphm-chu-marseille.bsky.social était ce matin sur @bfmmarseille.bsky.social
📽️ Découvrez comment notre technologie innovante est en train de changer la donne dans la lutte contre le cancer du cerveau www.bfmtv.com/marseille/re...
#glioblastome #Santé #RechercheMédicale
📽️ Découvrez comment notre technologie innovante est en train de changer la donne dans la lutte contre le cancer du cerveau www.bfmtv.com/marseille/re...
#glioblastome #Santé #RechercheMédicale
Marseille: une solution pour traiter le cancer du cerveau
VIDÉO - Le professeur Olivier Chinot, neuro-oncologue à l'APHM, présente un essai clinique innovant pour traiter le glioblastome, un cancer du cerveau.
www.bfmtv.com
June 5, 2025 at 9:59 AM
Le Pr. Olivier Chinot de @aphm-chu-marseille.bsky.social était ce matin sur @bfmmarseille.bsky.social
📽️ Découvrez comment notre technologie innovante est en train de changer la donne dans la lutte contre le cancer du cerveau www.bfmtv.com/marseille/re...
#glioblastome #Santé #RechercheMédicale
📽️ Découvrez comment notre technologie innovante est en train de changer la donne dans la lutte contre le cancer du cerveau www.bfmtv.com/marseille/re...
#glioblastome #Santé #RechercheMédicale
Our CSO will be onsite to present a poster about the Sonobird trial for rGBM during the International Society for Therapeutic Ultrasound event in Banff, Alberta, Canada from 21-24 June, 2025!
Find out more about the event and how you can register here👇
istu.org
#ISTU2025 #focusedultrasound
Find out more about the event and how you can register here👇
istu.org
#ISTU2025 #focusedultrasound
June 4, 2025 at 2:13 PM
Our CSO will be onsite to present a poster about the Sonobird trial for rGBM during the International Society for Therapeutic Ultrasound event in Banff, Alberta, Canada from 21-24 June, 2025!
Find out more about the event and how you can register here👇
istu.org
#ISTU2025 #focusedultrasound
Find out more about the event and how you can register here👇
istu.org
#ISTU2025 #focusedultrasound
🎧 LISTEN IN: Sound waves meet brain science.
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
May 29, 2025 at 7:01 AM
🎧 LISTEN IN: Sound waves meet brain science.
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
How do we overcome the blood-brain barrier ? 🧠
Despite advancements in #glioblastoma treatment, the BBB remains a critical obstacle.
In this Cureus article, part of Springer Nature, the authors suggest that one of the most promising uses of FUS is BBB disruption.
www.cureus.com/articles/353...
Despite advancements in #glioblastoma treatment, the BBB remains a critical obstacle.
In this Cureus article, part of Springer Nature, the authors suggest that one of the most promising uses of FUS is BBB disruption.
www.cureus.com/articles/353...
Overcoming the Blood-Brain Barrier: Focused Ultrasound in Glioblastoma Treatment
Despite recent advancements in neuro-oncology, glioblastoma remains one of the cancers with the poorest prognosis. Tumor recurrence and progression are driven by tumor stem cells and a high mutational...
www.cureus.com
May 27, 2025 at 7:35 AM
How do we overcome the blood-brain barrier ? 🧠
Despite advancements in #glioblastoma treatment, the BBB remains a critical obstacle.
In this Cureus article, part of Springer Nature, the authors suggest that one of the most promising uses of FUS is BBB disruption.
www.cureus.com/articles/353...
Despite advancements in #glioblastoma treatment, the BBB remains a critical obstacle.
In this Cureus article, part of Springer Nature, the authors suggest that one of the most promising uses of FUS is BBB disruption.
www.cureus.com/articles/353...
It's #ClinicalTrialsDay!
Clinical trials are essential to prove the safety and efficacy of our SonoCloud system in order to improve the treatment of brain diseases such as #Glioblastoma and neurodegenerative diseases.
Clinical trials are essential to prove the safety and efficacy of our SonoCloud system in order to improve the treatment of brain diseases such as #Glioblastoma and neurodegenerative diseases.
May 20, 2025 at 7:52 AM
It's #ClinicalTrialsDay!
Clinical trials are essential to prove the safety and efficacy of our SonoCloud system in order to improve the treatment of brain diseases such as #Glioblastoma and neurodegenerative diseases.
Clinical trials are essential to prove the safety and efficacy of our SonoCloud system in order to improve the treatment of brain diseases such as #Glioblastoma and neurodegenerative diseases.
Don't miss this article from NewYork-Presbyterian and @columbiacancer.bsky.social spotlighting our SONOBIRD trial
Huge thanks to Dr. Brian Gill and the team of researchers and clinicians driving this innovation
www.nyp.org/advances/art...
#Glioblastoma #BrainTumor #ClinicalTrials
Huge thanks to Dr. Brian Gill and the team of researchers and clinicians driving this innovation
www.nyp.org/advances/art...
#Glioblastoma #BrainTumor #ClinicalTrials
Disrupting the Blood-Brain Barrier to Improve Glioblastoma Treatment | Spotlight | Advances in Neurology and Oncology | NewYork-Presbyterian
NewYork-Presbyterian neurosurgeon Dr. Brian Gill describes the SONOBIRD trial, which tests a new implantable ultrasound device that may improve drug delivery to the brain to treat glioblastoma.
www.nyp.org
May 12, 2025 at 12:54 PM
Don't miss this article from NewYork-Presbyterian and @columbiacancer.bsky.social spotlighting our SONOBIRD trial
Huge thanks to Dr. Brian Gill and the team of researchers and clinicians driving this innovation
www.nyp.org/advances/art...
#Glioblastoma #BrainTumor #ClinicalTrials
Huge thanks to Dr. Brian Gill and the team of researchers and clinicians driving this innovation
www.nyp.org/advances/art...
#Glioblastoma #BrainTumor #ClinicalTrials